Precision Business Insights
Portfolio

 

Peptic Ulcer Drugs Market

: Global Market Estimation, Dynamics, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025

Global Peptic Ulcer Drugs Market: By Product Type (H2 receptor Antagonists, Proton Pump Inhibitors (PPIs), Antacids, Ulcer Protective Drugs, Potassium-Competitive Acid Blockers (P-CAB), Antibiotics, Others), By Formulation (Oral tablets, Effervescent Tablets, Effervescent Granules, Syrups, Injections), By Application (Oral tablets, Effervescent Tablets, Effervescent Granules, Syrups, Injections), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography

 

 

Global peptic ulcer drugs market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024.

 

Global Peptic Ulcer Drugs Market

 

Market Outline: Global Peptic Ulcer Drugs Market

Peptic ulcers are used in the treatment of certain types of gastrointestinal disorders that include gastric ulcers, gastritis, and duodenal ulcers or gastroesophagal reflux disease (GERD). These drugs minimize the amount of acid produced by the stomach. The most common symptoms associated with peptic ulcer include abdominal pain, vomiting, belching, poor appetite, and weight loss. Peptic ulcers can be treated by using various drugs such as proton pumps inhibitors (PPIs), H2 receptor antagonists, antacids, and antibiotics among others

 

Market Dynamics: Global Peptic Ulcer Drugs Market

Increase in the global geriatric population, rise in prevalence of peptic ulcers due to change in food habits, and increase in the consumption of tobacco and alcohol are key factors surge the global peptic ulcer drugs market. Moreover, rise in R&D for the development of newer drugs, rise in number of drug induced peptic ulcer cases, availability of cost-effective drugs, and rise in awareness about the peptic ulcers among the people are anticipated to surge the global peptic ulcer drugs market over the forecast years. However, adverse effects associated with the drugs, patent expiries of block buster drugs, poor pipeline products, and changes in pricing policies are hamper the growth of global peptic ulcer drugs market.

 

Market Scope: Global Peptic Ulcer Drugs Market

Global peptic ulcer drugs market is segmented based on product type, formulation, application, and distribution channel

Based on product type, market is segmented into the following:

  • H2 receptor Antagonists
  • Proton Pump Inhibitors (PPIs)
  • Antacids
  • Ulcer Protective Drugs
  • Potassium-Competitive Acid Blockers (P-CAB)
  • Antibiotics
  • Others

Based on formulation, market is segmented into the following

  • Oral tablets
  • Effervescent Tablets
  • Effervescent Granules
  • Syrups
  • Injections

Based on the application, market is segmented into the following:

  • Gastroesophagal Reflux Disease (GERD)
  • Gastritis
  • Duodenal Ulcers
  • Gastric Ulcers
  • Others

Geography

 North America

  • US
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe

Asia-Pacific

  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America

Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa

Rest of MEA

Based on the distribution channel, the market is segmented into the following:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Regional Analysis: Global Peptic Ulcer Drugs Market

Geographically, global peptic ulcer drugs market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America peptic ulcer drugs market is poised to grow due to rise in R&D for the development of newer drugs, increase in the prevalence of peptic ulcers due to change in lifestyle, and rise in health awareness among the people are propel the market. A lucrative growth observed in Europe peptic ulcer drugs market attributed to rise in consumption of tobacco and alcohol, high adoption of peptic ulcer drugs over various surgeries, and long term usage of various drugs such as pain medications that induce peptic ulcers are boost the market. However, Asia Pacific peptic ulcer drugs market is driving by entry of generic drugs due to patent expiries, rise in medical tourism for various surgeries, and large patient pool due to rise in geriatric population in India, china, and Japan are bolster the market.

 

Competition Assessment: Global Peptic Ulcer Drugs Market

Some of the players in the global peptic ulcer drugs market include:

  • Pfizer, Inc. (U.S.)
  • Boehringer Ingelheim GmbH (Germany)
  • Abbott Laboratories (U.S.)
  • Takeda Pharmaceuticals Co. Ltd (Japan)
  • GlaxoSmithKline plc (UK)
  • Yuhan Co. Ltd. (South Korea)
  • AstraZeneca plc (UK)
  • Eisai Co. Ltd. (U.S.)
  • Helicure AB (Sweden)
  • Cadila Healthcare (India)

Notable Market Developments: Global Peptic Ulcer Drugs Market

  • In February2018, Strides Shasun decided to launch the Ranitidine 150 mg over the counter drug in U.S. for the treatment of peptic ulcers
    
$ 3,000.00$ 8,900.00
Clear selection

Select License Type

Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner
FacebookTwitterLinkedinEmail

Our Clients

Testimonials